Early research (Phase 1)WithdrawnNCT04073160
What this trial is testing
TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer
Who this might be right for
Bladder Cancer
Daniel George, MD